Stocks & Options
Trading Strategies
Institutional Holdings Directory
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
enGene Therapeutics Inc. Reports Q2 2026 Financial Results
2026-06-15
SEC Filing 10-Q
(0001193125-26-270386)
Please check the link below for details.
Ticker mentioned:
ENGN
Source:
Original SEC Document β